Urafirin Capsule
Urafirin Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL23096105T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Manufacturer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Registration date
- 2023-09-19
- Published validity end
- 2028-09-19
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Nigella sativa | Nigella sativa[125 mg,450 mg] | Not identified |
| Plantago asiatica | Plantago asiatica[115 mg,450 mg] | Not identified |
| Urtica dioica | Urtica dioica[100 mg,450 mg] | Not identified |
| Serenoa repens | Serenoa repens[90 mg,450 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Nigella sativa[125 mg,450 mg],Plantago asiatica[115 mg,450 mg],Urtica dioica[100 mg,450 mg],Serenoa repens[90 mg,450 mg]
- Valid until
- 2028-09-19
- Registration date
- 2023-09-19
- Published description
- NATURAL PRODUCT
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Producer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Published name
- Urafirin Capsule
- Published reference
- 2023060911576T
- Registration number
- MAL23096105T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL23096105T
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.